In a filing, Ionis Pharmaceuticals Inc revealed its EVP Research Swayze Eric unloaded Company’s shares for reported $0.23 million on Jan 16 ’25. In the deal valued at $32.84 per share,7,154 shares were sold. As a result of this transaction, Swayze Eric now holds 45,670 shares worth roughly $1.56 million.
Then, Swayze Eric sold 22 shares, generating $719 in total proceeds. Upon selling the shares at $32.70, the EVP Research now owns 184 shares.
Before that, Schneider Eugene sold 6,523 shares. Ionis Pharmaceuticals Inc shares valued at $213,889 were divested by the EVP, Chf Clinical Develop Ofcr at a price of $32.79 per share. As a result of the transaction, Schneider Eugene now holds 58,508 shares, worth roughly $2.0 million.
BMO Capital Markets downgraded its Ionis Pharmaceuticals Inc [IONS] rating to a Market perform from a an Outperform in a research note published on August 02, 2024; the price target was decreased to $60 from $67. A number of analysts have revised their coverage, including Leerink Partners’s analysts, who increased its forecast for the stock in late July from “a Market perform” to “an Outperform”. Bernstein revised its rating on June 14, 2024. It rated IONS as “a Mkt perform” which previously was an “an Underperform”.
Price Performance Review of IONS
On Tuesday, Ionis Pharmaceuticals Inc [NASDAQ:IONS] saw its stock jump 0.18% to $34.11. Over the last five days, the stock has gained 4.38%. Ionis Pharmaceuticals Inc shares have fallen nearly -2.43% since the year began. Nevertheless, the stocks have fallen -33.87% over the past one year. While a 52-week high of $52.49 was reached on 01/02/25, a 52-week low of $31.40 was recorded on 01/17/25. SMA at 50 days reached $35.32, while 200 days put it at $40.91.
Levels Of Support And Resistance For IONS Stock
The 24-hour chart illustrates a support level at 33.68, which if violated will result in even more drops to 33.25. On the upside, there is a resistance level at 34.60. A further resistance level may holdings at 35.08. The Relative Strength Index (RSI) on the 14-day chart is 48.22, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.76, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 33.09%. Stochastics %K at 71.69% indicates the stock is a holding.
How much short interest is there in Ionis Pharmaceuticals Inc?
A steep rise in short interest was recorded in Ionis Pharmaceuticals Inc stocks on 2025-01-15, dropping by -0.29 million shares to a total of 10.24 million shares. Yahoo Finance data shows the prior-month short interest on 2024-12-13 was 10.53 million shares. There was a decline of -2.82%, which implies that there is a negative sentiment for the stock.
